FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to a pharmaceutical formulation, as well as to a method for its preparation. Implementation of the invention allows to obtain concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins.
EFFECT: such formulations may be administered by subcutaneous or intramuscular injection, instead of prolonged intravenous infusion.
23 cl, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIQUID COMPOSITIONS OF PROTEINS CONTAINING AGENTS FOR VISCOSITY REDUCTION | 2014 |
|
RU2710542C2 |
| LIQUID PROTEIN COMPOSITIONS CONTAINING VISCOSITY-REDUCING AGENTS | 2014 |
|
RU2782765C2 |
| ANTIBODY FORMULATIONS | 2012 |
|
RU2665810C2 |
| CONCENTRATED PROTEIN PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION | 2011 |
|
RU2626512C2 |
| HIGH-CONCENTRATION LIQUID ANTI-EGFR ANTIBODY COMPOSITIONS | 2005 |
|
RU2390353C2 |
| PREPARATIONS OF ANTIBODY TO THE ANTI-PROLACTIN RECEPTOR | 2013 |
|
RU2649372C2 |
| COMPOSITIONS OF ANTI-PD-1 ANTIBODIES | 2019 |
|
RU2772781C2 |
| PROTEIN COMPOSITIONS AND METHODS FOR PRODUCTION THEREOF | 2012 |
|
RU2659431C2 |
| COMPOSITIONS WITH PACLITAXEL, ALBUMIN AND BINDING AGENT AND METHODS FOR THEIR USE AND PREPARATION | 2017 |
|
RU2756892C2 |
| ANTIBODY COMPOSITION | 2015 |
|
RU2743681C2 |
